Abstract :

Stenotrophomonas maltophilia is a commensal and an emerging pathogen earlier noted in broad-spectrum life-threatening infections among the vulnerable, but more recently as a pathogen in immunocompetent individuals. In the current study, S. maltophilia was identified from 78% of vegetable samples. Bacterial population count ranged from 5.50 × 10^-1to 4.3 × 10^-4 cfu/g (mean 8.9 × 10⁵ cfu/g, median 7.75 × 10³ cfu/g). Based on a cross-sectional study performed during 2015-2016 n=35 and 2016-2017 n=55 S. maltophilia was isolated from clinical samples. The occurrence of S. maltophilia from clinical samples increased during 2016-2017 with a significant value of P=.0008. Out of the total of n=90 S. maltophilia, clinical isolates (35.28%) were from tracheal aspirates, followed by cerebrospinal fluid (CSF) (17.70%), sputum (15.20%), blood (16.82%), and urine (15.0%).  Sample sources were taken from different age groups of patients between 0-75 years. Almost all the isolates > 97% confirmed multiple drug resistance (MDR). Above 95% of the isolates are biofilm formers and the resistance rate increases among the biofilm formers.

---

Keywords :

Antibiotic resistance, biofilm formation, emerging pathogen, frequency of occurrence, S. maltophilia

---

References :

1. Abdallah, M., Benoliel, C., Drider, D. et al., (2014). Biofilm formation and persistence on abiotic surfaces in the context of food and medical environments. Arch Microbiol 196, 453–472. https://doi.org/10.1007/s00203-014-0983-1
2. Adegoke, A. A., Stenström, T. A., & Okoh, A. I. (2017). Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy. Frontiers in microbiology, 8, 2276.
3. Adjidé, C. C., De Meyer, A., Weyer, M., Obin, O., Lamory, F., Lesueur, C., et al. (2010). Stenotrophomonas maltophilia and Pseudomonas aeruginosa water-associated microbiologic risk assessment in Amiens’ University Hospital Centre. Pathol. Biol. 58, e1–e5. doi: 10.1016/j.patbio.2009.07.006
4. Alavi P., Starcher M. R., Thallinger G. G., Zachow C., Müller H., Berg G. (2014). Stenotrophomonas comparative genomics reveals genes and functions that differentiate beneficial and pathogenic bacteria. BMC Genomics 15:482. 10.1186/1471-2164-15-482
5. Anusree Thenissery, Rithu Chandran, Rajasekhar Ravindran, Chintu Ravishankar, Jishnu Haridas Piriyath, (2022). Isolation and identification of emergent multidrug-resistant Stenotrophomonas maltophilia from skin ulcers of Sarcoptes-infested pigs; Vet-Record case report; PP. Volume10, Issue2
6. Bin Cai, Glenn Tillotson, Darrin Benjumea, Patrick Callahan, Roger Echols, (2020). The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study, Open Forum Infectious Diseases, Volume 7, Issue 5, May 2020, ofaa141,
7. Biswas S, Berwal A, Chawla K., (2020). A prospective study of microbiological characterization and clinical facets of Stenotrophomonas maltophilia Iran J Microbiol. 2020 Aug;12(4):313-318. doi: 10.18502/ijm. v12i4.3934. PMID: 32994902; PMCID: PMC7502144.
8. Bostanghadiri, N., Ardebili, A., Ghalavand, Z. et al. (2021). Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates. BMC Res Notes 14, 151 (2021).
9. Brooke JS, (2012). Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. Jan;25(1):2-41.
10. Brooke JS, (2014). New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen. Expert Rev Anti Infect Ther. Jan;12(1):1-4.
11. Chang, Y. T., Lin, C. Y., Chen, Y. H., & Hsueh, P. R. (2015). Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Frontiers in microbiology, 6, 893.
12. Di Bonaventura G, Spedicato I, D’Antonio D, Robuffo I, Piccolomini R. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother. 2004 Jan;48(1):151-60. doi: 10.1128/AAC.48.1.151-160.2004. PMID: 14693533; PMCID: PMC310151.
13. Elvers, K. T., K. Leeming, and H. M. Lappin-Scott, (2001). Binary culture biofilm formation by Stenotrophomonas maltophilia and Fusarium oxysporum. J. Ind. Microbiol. Biotechnol. 26:178-183.
14. Gajdács, M., & Urbán, E. (2019). Prevalence and Antibiotic Resistance of Stenotrophomonas maltophilia in Respiratory Tract Samples: A 10-Year Epidemiological Snapshot. Health services research and managerial epidemiology, 6, 2333392819870774.
15. Gibb, J., & Wong, D. W. (2021). Antimicrobial Treatment Strategies for Stenotrophomonas maltophilia: A Focus on Novel Therapies. Antibiotics (Basel, Switzerland), 10(10), 1226. https://doi.org/10.3390/antibiotics10101226
16. Gil-Gil, T., Martínez, J. L., & Blanco, P. (2020). Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge. Expert review of anti-infective therapy, 18(4), 335–347
17. Hentrich M., Schalk E., Schmidt-Hieber M., Chaberny I., Mousset S. (2014). Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases, Working Party of the German Society of Hematology and Medical Oncology. Ann. Oncol. 25, 936–947. 10.1093/annonc/mdt545
18. Hu L-F, et al., 2011. Stenotrophomonas maltophilia resistance to trimethoprim/sulfamethoxazole mediated by acquisition of sul and dfrA genes in a plasmid-mediated class 1 integron. Int. J. Antimicrob. Agents 37:230–234
19. Hutinel, M., Larsson, D. J., & Flach, C. F. (2022). Antibiotic resistance genes of emerging concern in municipal and hospital wastewater from a major Swedish city. Science of The Total Environment, 812, 151433.
20. Jayol A, Corlouer C, Haenni M, Darty M, Maillard K, Desroches M, Lamy B, Jumas-Bilak E, Madec JY, Decousser J, (2018). Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study. Eur J Clin Microbiol Infect Dis. Jun;37(6):1039-1045.
21. Jucker, B. A., H. Harms, and A. J. Zehnder. 1996. Adherence of the positively charged bacterium Stenotrophomonas (Xanthomonas) maltophilia 70401 to glass and Teflon. J. Bacteriol. 178:5472-5479.
22. Koch, C., and N. Høiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
23. Lambert B, Meire P, Joos H, Lens P, Swings J. Fast-growing, aerobic, heterotrophic bacteria from the rhizosphere of young sugar beet plants. Appl Environ Microbiol. 1990; 56:3375–3381.
24. Li, D., Wong, C. H., Seet, M. F., & Kuan, N. (2019). Isolation, Characterization, and Inactivation of Stenotrophomonas maltophilia From Leafy Green Vegetables and Urban Agriculture Systems. Frontiers in microbiology, 10, 2718.
25. Miles Denton and Kevin G. Kerr (1998). Microbiological and Clinical Aspects of Infection associated with Stenotrophomonas maltophilia; ASM; Clinical Microbiology Reviews, Volume 11, Issue 1, 1 January 1998, Pages 57-80
26. Mojica, M. F., Humphries, R., Lipuma, J. J., Mathers, A. J., Rao, G. G., Shelburne, S. A., Fouts, D. E., Van Duin, D., & Bonomo, R. A. (2022). Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC-antimicrobial resistance, 4(3), dlac040.
27. Mojica, M. F., Humphries, R., Lipuma, J. J., Mathers, A. J., Rao, G. G., Shelburne, S. A., Fouts, D. E., Van Duin, D., & Bonomo, R. A. (2022). Clinical challenges treating Stenotrophomonas maltophilia infections: an update. JAC-antimicrobial resistance, 4(3), dlac040.
28. Nseir, S., Di Pompeo, C., Brisson, H., Dewavrin, F., Tissier, S., Diarra, M., Boulo, M., & Durocher, A. (2006). Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Critical care (London, England), 10(5), R143.
29. O’Toole, G.A. (2011) Microtiter Dish Biofilm Formation Assay. Journal of Visualized Experiments, 47, 2437
30. Polianciuc SI, Gurzău AE, Kiss B, Ştefan MG, Loghin F. (2020). Antibiotics in the environment: causes and consequences. Med Pharm Rep. 2020 Jul;93(3):231-240. doi: 10.15386/mpr-1742. Epub 2020 Jul 22. PMID: 32832887; PMCID: PMC7418837.
31. Qureshi, A., Mooney, L., Denton, M., & Kerr, K. G. (2005). Stenotrophomonas maltophilia in salad. Emerging infectious diseases, 11(7), 1157–1158.
32. Said MS, Tirthani E, Lesho E. Stenotrophomonas maltophilia. [Updated 2022 Jun 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022
33. Stepanović, S., Vuković, D., Hola, V., Di Bonaventura, G., Djukić, S., Cirković, I., & Ruzicka, F. (2007). Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci; Journal of Pathology, Microbiology and Immunology; Scandinavica, Volume115 (8), PP 891-899.
34. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ, (2022). Infectious Diseases Society of America Guidance on the Treatment of AmpC β-lactamase-Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infectious Diseases Society of America; Version 2.0.
35. Wang, N., Tang, C., & Wang, L. (2022). Risk Factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: A Systematic Review and Meta-Analysis. Frontiers in medicine, 8, 808391.
36. Waters V., Atenafu E. G., Salazar J. G., Lu A., Yau Y., Matukas L., (2012). Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. J. Cyst. Fibros. 11, 8–13 10.1016/j.jcf.2011.07.008
37. Willsey GG, Eckstrom K, LaBauve AE, Hinkel LA, Schutz K, Meagher RJ, LiPuma JJ, Wargo MJ, (2019). Stenotrophomonas maltophilia Differential Gene Expression in Synthetic Cystic Fibrosis Sputum Reveals Shared and Cystic Fibrosis Strain-Specific Responses to the Sputum Environment. J Bacteriol. Aug 01;201(15)
38. Yeshurun M., Gafter-Gvili A., Thaler M., Keller N., Nagler A., Shimoni A. (2010). Clinical characteristics of Stenotrophomonas maltophilia infection in hematopoietic stem cell transplantation recipients: a single center experience. Infection 38, 211–215. 10.1007/s15010-010-0023-2
39. Youenou, B., Favre-Bonté, S., Bodilis, J., Brothier, E., Dubost, A., Muller, D., & Nazaret, S. (2015). Comparative Genomics of Environmental and Clinical Stenotrophomonas maltophilia Strains with Different Antibiotic Resistance Profiles. Genome biology and evolution, 7(9), 2484–2505. https://doi.org/10.1093/gbe/evv161
40. Zając OM, Tyski S, Laudy AE, (2022). Phenotypic and Molecular Characteristics of the MDR Efflux Pump Gene-Carrying Stenotrophomonas maltophilia Strains Isolated in Warsaw, Poland. Biology. PP; 11(1):105